Healthcare -
Biotechnology - NASDAQ - US
$ 148.39
2.47 %
$ 4.27 B
Market Cap
82.9
P/E
KRYS - COST OF REVENUE
Cost of Revenue KRYS - Krystal Biotech, Inc.
3.09 M
LAST VALUE
5.71%
2 YEAR CAGR
85.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR